19 reports

Surgery of the gastrointestinal tract can often be performed in the outpatient setting.

  • Cough And Cold
  • China
  • Demand
  • Forecast
  • Market Size

(India) ##.

  • Cough And Cold
  • United States
  • World
  • Demand
  • Market Shares

FOLLOWED TYPES ARE THE GASTROINTESTINAL TRACT TYPE, SKIN TYPE OTC DRUGS.

  • Cough And Cold
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Taiji Group

The structural ##.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade

FOLLOWED TYPES ARE THE GASTROINTESTINAL TRACT TYPE, SKIN TYPE OTC DRUGS.

  • Cough And Cold
  • China
  • Demand
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited

(USA) ##.

  • Cough And Cold
  • United States
  • World
  • Demand
  • Market Shares

Chapter Six: Gastrointestinal Drugs Figure ##-## U. S.

  • Cough And Cold
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

The structural ##.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc
  • PLAYER PERFORMANCE CONTINUED

High capital intensity is more than $##. ## of capital to $## of labor; medium is $##. ## to $##. ## of capital to $## of labor; low is less than $##. ## of capital for every $## of labor.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • United States
  • Demand
  • Nasopharyngitis (Common Cold) - Drug Profiles

Nasopharyngitis (Common Cold) - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngitis (Common Cold) - Pipeline Review, H2 2018, provides an overview of the Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline...

  • Cough And Cold
  • United States
  • World
  • Company Sales
  • Product Initiative

One of the Phase IIa studies was in Cystic Fibrosis patients with statistically significant increases in average forced expiratory volume in one second.

  • Cough And Cold
  • Healthcare
  • Pharmaceutical
  • United States
  • Vernalis plc

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Cough And Cold
  • Norway
  • Company Financials
  • M&A
  • Weifa

DISCLAIMER DISCLAIMER For information regarding permission, contact: Tel: ##-##-##-## www. marketsandmarkets. com US Toll Free: ##-##-##-##

  • Cough And Cold
  • Drug Delivery
  • North America
  • United States
  • Market Size
  • SINUSITIS - PIPELINE BY OPTINOSE US INC, H1 2018
  • SINUSITIS - PIPELINE BY PFIZER INC, H1 2018

Twentytwo percent of oral immunotherapy doses in omalizumab patients and ## percent of doses for placebo patients caused gastrointestinal side effects, while ## and ## percent of doses caused respiratory side effects in the omalizumab and placebo groups, respectively.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Nasopharyngitis (Common Cold) - Drug Profiles

Nasopharyngitis (Common Cold) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngitis (Common Cold) - Pipeline Review, H1 2018, provides an overview of the Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline...

  • Cough And Cold
  • Respiratory Disease
  • United States
  • World
  • Product Initiative
  • SINUSITIS - PIPELINE BY QUORUM INNOVATIONS LLC, H2 2017
  • SINUSITIS - PIPELINE BY PFIZER INC, H2 2017

QUORUM OFFERS LEAD DRUG IN AREAS OF CHRONIC INFLAMMATORY SKIN DISEASES, CHRONIC INFLAMMATORY GASTROINTESTINAL DISEASES, ONCOLOGY APPLICATION ACTIVE DEVELOPMENT, ANTI-BIOFILM AND ANTI-INFLAMMATORY THERAPEUTICS.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • Australia
  • United States

The prominent features of this report are - ##.

  • Clinical Trial
  • Cough And Cold
  • Drug Discovery And Development
  • World
  • Product Initiative

Other adverse events: May ##, 2014 Total, other (not including serious) adverse events Gastrointestinal disorders Diarrhoea VA/ AMP##C (##:##) ##/ ## ##/ ## (##. ##%) ##/ ## (##. ##%) ##/ ## (##. ##%) Nausea Otitis media http:/ / clinicaltrials. gov/ ct##

  • Cough And Cold
  • Drug Discovery And Development
  • World
  • Market Size
  • Product Initiative

CORPLEX DONEPEZIL WAS WELL TOLERATED WITH FAVORABLE ADHESION, SKIN SAFETY AND GASTROINTESTINAL SIDE EFFECT PROFILES.

  • Anesthetics
  • Clinical Trial
  • Cough And Cold
  • Pharmaceutical
  • Opiant Pharmaceuticals, Inc.